This increase in survival reflects the increased use of prostate-specific antigen (PSA) testing, which has led to the diagnosis of many asymptomatic prostatic cancers that would never have been diagnosed in life (Brewster et al, 2000; Evans and Moller, 2003). Here, KLK3 is linked to prostate carcinoma.